16405 Abrocitinib treatment in patients with moderate to severe atopic dermatitis: Consistency of efficacy responses from randomized, controlled phase 3 and phase 2b clinical trials
2020 ◽
Vol 83
(6)
◽
pp. AB62
Keyword(s):
Phase 3
◽